247 related articles for article (PubMed ID: 26393889)
1. A Prussian Blue-Based Core-Shell Hollow-Structured Mesoporous Nanoparticle as a Smart Theranostic Agent with Ultrahigh pH-Responsive Longitudinal Relaxivity.
Cai X; Gao W; Ma M; Wu M; Zhang L; Zheng Y; Chen H; Shi J
Adv Mater; 2015 Nov; 27(41):6382-9. PubMed ID: 26393889
[TBL] [Abstract][Full Text] [Related]
2. Composition-property relationships in multifunctional hollow mesoporous carbon nanosystems for PH-responsive magnetic resonance imaging and on-demand drug release.
Zhang S; Qian X; Zhang L; Peng W; Chen Y
Nanoscale; 2015 May; 7(17):7632-43. PubMed ID: 25785502
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.
Li X; Zhao W; Liu X; Chen K; Zhu S; Shi P; Chen Y; Shi J
Acta Biomater; 2016 Jan; 30():378-387. PubMed ID: 26602820
[TBL] [Abstract][Full Text] [Related]
4. Indocyanine green-modified hollow mesoporous Prussian blue nanoparticles loading doxorubicin for fluorescence-guided tri-modal combination therapy of cancer.
Yang R; Hou M; Gao Y; Zhang L; Xu Z; Kang Y; Xue P
Nanoscale; 2019 Mar; 11(12):5717-5731. PubMed ID: 30865744
[TBL] [Abstract][Full Text] [Related]
5. A multifunctional nanotheranostic for the intelligent MRI diagnosis and synergistic treatment of hypoxic tumor.
Song R; Zhang M; Liu Y; Cui Z; Zhang H; Tang Z; Chen X; Wu H; Yao Z; He M; Bu W
Biomaterials; 2018 Aug; 175():123-133. PubMed ID: 29804000
[TBL] [Abstract][Full Text] [Related]
6. Tailored ultra-small Prussian blue-based nanoparticles for MRI imaging and combined photothermal/photoacoustic theranostics.
Fétiveau L; Paul G; Nicolas-Boluda A; Volatron J; George R; Laurent S; Muller R; Sancey L; Mejanelle P; Gloter A; Gazeau F; Catala L
Chem Commun (Camb); 2019 Dec; 55(98):14844-14847. PubMed ID: 31768507
[TBL] [Abstract][Full Text] [Related]
7. Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.
Guillet-Nicolas R; Laprise-Pelletier M; Nair MM; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Kleitz F; Fortin MA
Nanoscale; 2013 Dec; 5(23):11499-511. PubMed ID: 24178890
[TBL] [Abstract][Full Text] [Related]
8. Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery.
Chen Y; Chen H; Zhang S; Chen F; Sun S; He Q; Ma M; Wang X; Wu H; Zhang L; Zhang L; Shi J
Biomaterials; 2012 Mar; 33(7):2388-98. PubMed ID: 22177841
[TBL] [Abstract][Full Text] [Related]
9. Real-time monitoring of arsenic trioxide release and delivery by activatable T(1) imaging.
Zhao Z; Wang X; Zhang Z; Zhang H; Liu H; Zhu X; Li H; Chi X; Yin Z; Gao J
ACS Nano; 2015 Mar; 9(3):2749-59. PubMed ID: 25688714
[TBL] [Abstract][Full Text] [Related]
10. Theranostic magnetite cluster@silica@albumin double-shell particles as suitable carriers for water-insoluble drugs and enhanced T2 MR imaging contrast agents.
Maboudi SA; Shojaosadati SA; Aliakbari F; Arpanaei A
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1485-1492. PubMed ID: 30889683
[TBL] [Abstract][Full Text] [Related]
11. A theranostic system based on nanocomposites of manganese oxide nanoparticles and a pH sensitive polymer: Preparation, and physicochemical characterization.
Samiei Foroushani M; Niroumand N; Karimi Shervedani R; Yaghoobi F; Kefayat A; Torabi M
Bioelectrochemistry; 2019 Dec; 130():107347. PubMed ID: 31437809
[TBL] [Abstract][Full Text] [Related]
12. Albumin-MnO
Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T
Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612
[TBL] [Abstract][Full Text] [Related]
13. "Manganese Extraction" Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles.
Yu L; Chen Y; Wu M; Cai X; Yao H; Zhang L; Chen H; Shi J
J Am Chem Soc; 2016 Aug; 138(31):9881-94. PubMed ID: 27441571
[TBL] [Abstract][Full Text] [Related]
14. Composite iron oxide-Prussian blue nanoparticles for magnetically guided T
Kale SS; Burga RA; Sweeney EE; Zun Z; Sze RW; Tuesca A; Subramony JA; Fernandes R
Int J Nanomedicine; 2017; 12():6413-6424. PubMed ID: 28919744
[TBL] [Abstract][Full Text] [Related]
15. A tantalum oxide-based core/shell nanoparticle for triple-modality image-guided chemo-thermal synergetic therapy of esophageal carcinoma.
Jin Y; Ma X; Zhang S; Meng H; Xu M; Yang X; Xu W; Tian J
Cancer Lett; 2017 Jul; 397():61-71. PubMed ID: 28351615
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous composite nanoparticles for dual-modality ultrasound/magnetic resonance imaging and synergistic chemo-/thermotherapy against deep tumors.
Zhang N; Wang R; Hao J; Yang Y; Zou H; Wang Z
Int J Nanomedicine; 2017; 12():7273-7289. PubMed ID: 29042775
[TBL] [Abstract][Full Text] [Related]
17. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells.
Chen Y; Yin Q; Ji X; Zhang S; Chen H; Zheng Y; Sun Y; Qu H; Wang Z; Li Y; Wang X; Zhang K; Zhang L; Shi J
Biomaterials; 2012 Oct; 33(29):7126-37. PubMed ID: 22789722
[TBL] [Abstract][Full Text] [Related]
18. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
[TBL] [Abstract][Full Text] [Related]
19. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
20. pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents.
Huang X; Yuan Y; Ruan W; Liu L; Liu M; Chen S; Zhou X
J Nanobiotechnology; 2018 Mar; 16(1):30. PubMed ID: 29587764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
